TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 42 filers reported holding TFF PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $13,000 | -80.3% | 3,213 | -69.6% | 0.00% | – |
Q1 2022 | $66,000 | -71.6% | 10,566 | -59.7% | 0.00% | – |
Q4 2021 | $232,000 | -3.3% | 26,239 | +10.1% | 0.00% | – |
Q3 2021 | $240,000 | +3.4% | 23,835 | -1.7% | 0.00% | – |
Q2 2021 | $232,000 | +11500.0% | 24,235 | +11664.6% | 0.00% | – |
Q4 2020 | $2,000 | -98.5% | 206 | -97.1% | 0.00% | – |
Q3 2020 | $132,000 | – | 7,181 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 1,350,000 | $19,332,000 | 4.60% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 220,666 | $3,160,000 | 3.42% |
Mesirow Financial Investment Management, Inc. | 27,963 | $400,430,000 | 1.27% |
Gagnon Advisors, LLC | 176,471 | $2,527,000 | 1.14% |
PRECEPT MANAGEMENT LLC | 150,000 | $2,148,000 | 0.87% |
Nantahala Capital Management | 1,763,476 | $25,253,000 | 0.78% |
GAGNON SECURITIES LLC | 232,865 | $3,335,000 | 0.53% |
Sepio Capital, LP | 92,084 | $1,319,000 | 0.11% |
683 Capital Management, LLC | 142,024 | $2,034,000 | 0.10% |
SANDERS MORRIS HARRIS LLC | 21,326 | $394,000 | 0.09% |